c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)

The VRK1 kinase is a novel Ser-Thr kinase in the human kinome that diverged from the casein kinase 1 branch. These kinases phosphorylate transcription factors related to stress responses, such as p53. In this report we have studied the phosphorylation of the transcription factor c-Jun in its N-terminal region. The VRK1 protein phosphorylates c-Jun with a Km of 0.4 μM, and is not inhibited by SP600125. VRK1 phosphorylates c-Jun in Ser63 and Ser73 in vitro, the same residues targeted by the N-terminal kinase of c-Jun (JNK). This phosphorylation induces the stabilization and accumulation of the c-Jun protein. VRK1 phosphorylates the endogenous c-Jun in Ser63. VRK1 activates c-Jun dependent transcription, which is dependent on phosphorylation of Ser63 and Ser73. The c-Jun with Ser63Ala and Ser73Ala substitutions is not transcriptionally active when cotransfected with VRK1. VRK1 interacts with c-Jun but not with JNK. The cotransfection of VRK1 and JNK has an additive effect on the transcriptional activation of c-Jun indicating that they can cooperate when both are at suboptimal dose; otherwise, maximum effect by one of them prevents the effect of the other. The VRK1-c-Jun connection represents a component of a new signaling pathway whose upstream elements remain to be identified.

[1]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[2]  P. Lazo,et al.  Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. , 2002, Archives of biochemistry and biophysics.

[3]  M. Saraste,et al.  FEBS Lett , 2000 .

[4]  P. Lazo,et al.  Expression of the VRK (vaccinia‐related kinase) gene family of p53 regulators in murine hematopoietic development , 2003, FEBS letters.

[5]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[6]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[7]  Dirk Bohmann,et al.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.

[8]  J. Nezu,et al.  Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. , 1997, Genomics.

[9]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.

[10]  D. Edwards,et al.  The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1* , 2003, The Journal of Biological Chemistry.

[11]  Z. Ronai,et al.  Stability of the ATF2 Transcription Factor Is Regulated by Phosphorylation and Dephosphorylation* , 2000, The Journal of Biological Chemistry.

[12]  Tsonwin Hai,et al.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. , 2001, Gene.

[13]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[14]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[15]  M. Yunta,et al.  Differential Cooperation between Regulatory Sequences Required for Human CD53 Gene Expression* , 2001, The Journal of Biological Chemistry.

[16]  R. Flavell,et al.  Regulation of c-Jun NH2-terminal Kinase ( Jnk) Gene Expression during T Cell Activation , 2000, The Journal of experimental medicine.

[17]  R. Quatrano.  Genomics , 1998, Plant Cell.

[18]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[19]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[20]  P. Lazo,et al.  Transient activation of the c-Jun N-terminal kinase (JNK) activity by ligation of the tetraspan CD53 antigen in different cell types. , 2002, European journal of biochemistry.

[21]  Hans van Dam,et al.  Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis , 2001, Oncogene.

[22]  P. Lazo,et al.  The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein , 2000, Oncogene.

[23]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[24]  M. Volm,et al.  Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. , 1993, Carcinogenesis.

[25]  R. Nichols,et al.  Characterization of Three Paralogous Members of the Mammalian Vaccinia Related Kinase Family* , 2004, Journal of Biological Chemistry.

[26]  J. Coligan,et al.  ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. , 1997, The Journal of biological chemistry.

[27]  Claudio R. Santos,et al.  Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK* , 2004, Journal of Biological Chemistry.

[28]  D. Gillespie,et al.  Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. , 2002, Cellular signalling.

[29]  A. Grinberg,et al.  DNA sequence‐dependent folding determines the divergence in binding specificities between Maf and other bZIP proteins , 2001, The EMBO journal.

[30]  R. Flavell,et al.  JNK is required for effector T-cell function but not for T-cell activation , 2000, Nature.

[31]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[32]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[33]  F. Calabrese,et al.  C-JUN and CPP32 (CASPASE 3) in Human Pancreatic Cancer: Relation to Cell Proliferation and Death , 2003, Pancreas.

[34]  P. Duesberg,et al.  Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations , 2003, Cell cycle.

[35]  References , 1971 .

[36]  A. Clerk,et al.  Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes. , 1997, The Biochemical journal.

[37]  Mehdi Tnani,et al.  Elevated JNK activation contributes to the pathogenesis of human brain tumors , 2002, Oncogene.

[38]  V. Hu.  The Cell Cycle , 1994, GWUMC Department of Biochemistry Annual Spring Symposia.

[39]  T. Curran,et al.  Selective DNA bending by a variety of bZIP proteins , 1993, Molecular and cellular biology.

[40]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Neal,et al.  c-jun oncogene expression in transitional cell carcinoma of the urinary bladder. , 1994, British journal of urology.